Patent · US Active

Methods of accelerating or improving wound healing using IL-22 FC fusion proteins

US10544198B2 · kind B2 · utility

0Cited by

54References

40Claims

0Family size

Assignee

Genentech, Inc. · US

Inventors

Justin Scheer · San Francisco, US
Wenjun Ouyang · Foster City, US
Richard Vandlen · Hillsborough, US
Philip E. Hass · Moss Beach, US
Eric Gary Stefanich · Emerald Hills, US
Xiaoting Wang · Berkeley, US
Ganesh A. Kolumam · Foster City, US
Wyne P. LEE · Millbrae, US

Key dates

Filing date	Mar 9, 2017
Grant date	Jan 28, 2020
Priority date	—
Expiry date	Mar 9, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to IL-22 polypeptides, IL-22 Fc fusion proteins and IL-22 agonists, composition comprising the same, methods of making and methods of using the composition for the treatment of diseases. The invention also relates to IL-22 receptor associated reagents and methods of use thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.